MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1

BACKGROUND: Cervical cancer patients have a high risk of metastasis and a poor prognosis with shorter disease-free survival. Thus, novel biomarkers and feasible therapies urgently need to be discovered. Previous studies have shown that miR-95-3p plays crucial roles in several cancer types. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Sijie, Lu, Yunkun, Sun, Lisha, Hao, Shuangying, Liu, Zhiqiang, Yang, Fangyuan, Zhang, Lin, Wang, Ting, Jiang, Lihong, Zhang, Juan, Liu, Shuyan, Pang, Hui, Wang, Zhenhui, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708496/
https://www.ncbi.nlm.nih.gov/pubmed/36467343
http://dx.doi.org/10.21037/atm-22-5184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708496/
https://www.ncbi.nlm.nih.gov/pubmed/36467343
http://dx.doi.org/10.21037/atm-22-5184

Ejemplares similares